Clinical Trials
Source: CCM
- Score: 14Digestive System
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
- Ages12 years - 75 years
- GenderBoth
- Score: 13Children's Health, Immune System, Arthritis
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Ages2 years - 21 years
- GenderBoth
- Score: 12Liver, Obesity & Weight Management
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
- Ages12 years - 18 years
- GenderBoth
- Score: 11Digestive System
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
- Ages18 years - 75 years
- GenderBoth
- Score: 10Children's Health, Genetics
Pediatric Genomics Discovery Program (PGDP)
- GenderBoth
- Score: 9Digestive System
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
- Ages18 years - 75 years
- GenderBoth
- Score: 8Skin/Dermatology, Genetics
The ASCEND Study
- Ages6 years and older
- GenderBoth
- Score: 7Skin/Dermatology, Genetics
Does Ichthyosis Affect Growth Among Children?
- Ages25 years and younger
- GenderBoth
- Score: 6
Intestinal Immunity in Neurologic Disease
- Score: 5Infectious Disease, Men's Health, Women's Health
EPIC-P Intervention
- Ages18 years and older
- GenderBoth